Privacy Analytics - Articles Archive

Articles

October 28, 2020

FPF Privacy and Pandemics Position Statement

We believe that data-driven insights are critical to addressing challenges introduced by the current pandemic, and that benefits can be realized while respecting privacy….

Articles

October 28, 2020

How anonymization can enrich every stage of the drug development lifecycle

I wrote in our September newsletter about how trial sponsors are well advised to view transparency as much more than just a box that…

Articles

September 9, 2020

Beyond a Box Tick: Transparency is a business enabler for trial sponsors

Pharmaceutical companies today are well-advised to view transparency as an opportunity to enhance their reputation in the marketplace and earn trust with stakeholders, which…

Articles

June 10, 2020

A Culture of Collaboration

A message from Director of Technology Khaldoun Zine El Abidien Collaboration is a common thread at Privacy Analytics, running through all aspects of our…

Articles

June 10, 2020

A Passion for Excellence

When I think about what passion looks like at Privacy Analytics, it’s a quiet, underlying drive to innovate and push for a better world….

Articles

May 4, 2020

One Year In: How the Opening of Health Canada’s Portal Affects You

An article by Niamh McGuinness, Senior Analyst, CTT, Privacy Analytics Just over a year ago, Health Canada stipulated that all clinical trials documents needed…

Articles

April 15, 2020

Putting Our Passion into Action Against COVID-19

A message from Sarah Lyons, General Manager, Privacy Analytics Privacy Analytics is wholly committed to the global effort to respond to COVID-19. We have…

Articles

December 19, 2019

Turn Data Assets into Business Opportunity Under CCPA

Business Problem How the CCPA is changing the legislative landscape Since the California Consumer Privacy Act was signed in 2018, multiple other states have…

Articles

November 21, 2019

Can You Comply Your Way to Greatness?

An article by Sarah Lyons – Senior Director, Operations I recently heard something that stuck with me: “Nobody complies their way to greatness.” An…

Articles

September 26, 2019

When to Integrate Anonymization of Documents and Data

An article by Sarah Lyons – Senior Director, Operations Should sponsors integrate risk-based anonymization across both documents and structured individual patient data (S-IPD)? The…

FPF Privacy and Pandemics Position Statement

How anonymization can enrich every stage of the drug development lifecycle

Beyond a Box Tick: Transparency is a business enabler for trial sponsors

A Culture of Collaboration

A Passion for Excellence

One Year In: How the Opening of Health Canada’s Portal Affects You

Putting Our Passion into Action Against COVID-19

Turn Data Assets into Business Opportunity Under CCPA

Can You Comply Your Way to Greatness?

When to Integrate Anonymization of Documents and Data

Not finding what you're looking for?

Filter by Data Type

Categories

Join the next 5 Safes Data Privacy webinar